Hosted on MSN4h
Bristol Myers Raises Profit Forecast on Drug Demand
(Bloomberg) -- Bristol Myers Squibb Co. raised its 2024 profit forecast as demand ... The anti-inflammatory Sotyktu, the heart drug Camzyos, and the anemia treatment Reblozyl — three drugs on which ...
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC) and no known epidermal growth factor receptor (EGFR) ...
inforum18h
FDA approves the first new schizophrenia drug in over 30 years
FARGO — A new FDA approved drug, to help people with schizophrenia, will soon be accessible for medical officials to ...
stocknews21h
3 Pharmaceutical Stocks That Could Lead the Next Drug Revolution
The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...
Crain's New York23h
Big pharma companies lay off hundreds amid tepid sales and legal battles
The cuts follow an ongoing wave of staff reductions at big drug companies. Pharma giants have terminated thousands of ...